PLIN5 and metabolic dysfunction-associated steatotic liver disease: Broadening the network of PLIN5 targets and cofactors in distinct stages of NAFLD-HCC pathogenesis will help to characterize more specific roles of PLIN5, potentially allowing the use of this protein as a tool for diagnosis or therapeutic targeting.